Results 81 to 90 of about 520 (99)

Relation between door-to-balloon times and mortality after primary percutaneous coronary intervention over time: a retrospective study

Lancet, The, 2015
Brahmajee K Nallamothu, Sharon-Lise T Normand, Yongfei Wang   +2 more
exaly  

Strategies for Reducing the Door-to-Balloon Time in Acute Myocardial Infarction

New England Journal of Medicine, 2006
Jeph Herrin, Barbara A Barton, Harlan M Krumholz   +2 more
exaly  

Door-to-door travel in 2035 – A Delphi study

Technological Forecasting and Social Change, 2020
Stefan Spinler
exaly  

Improvements in Door-to-Balloon Time in the United States, 2005 to 2010

Circulation, 2011
Harlan M Krumholz, Jeph Herrin
exaly  

The Medicare-HMO Revolving Door — The Healthy Go in and the Sick Go Out

New England Journal of Medicine, 1997
Beth A Virnig
exaly  

Nanoparticle opens door to cerebral palsy treatment

Nature Reviews Drug Discovery, 2012
exaly  

Achieving Rapid Door-To-Balloon Times

Circulation, 2006
Barbara A Barton, Harlan M Krumholz
exaly  

Opening the door to a new class of proteasome inhibitors

Nature Reviews Drug Discovery, 2012
exaly  

Amarin agreement opens off-label promotion door

Nature Reviews Drug Discovery, 2016
exaly  

Prognostic Implications of Door‐to‐Balloon Time and Onset‐to‐Door Time on Mortality in Patients With ST‐Segment–Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention

Journal of the American Heart Association, 2019
Joo Myung Lee, Hyun Kuk Kim, Doyeon Hwang   +2 more
exaly